Apogee's Zumilokibart Shows Promise for Eczema in 2026
Apogee Therapeutics' zumilokibart showed skin clearance and itch relief for atopic dermatitis with less frequent injections in mid-stage trial results.
By Robert Kim
clinical-trial
4 articles tagged "clinical-trial"
Eli Lilly's Retatrutide Cuts Blood Sugar & Weight in Trial
Eli Lilly's triple-G drug retatrutide showed significant HbA1C and weight reductions in type 2 diabetes patients at 40 weeks in a 2026 late-stage trial.
Tecovirimat in the Treatment of Mpox: Clinical Efficacy and Therapeutic Implications
A comprehensive analysis of tecovirimat's clinical efficacy in mpox treatment demonstrates significant reduction in lesion resolution time and viral shedding duration. The findings establish tecovirimat as a viable therapeutic option for severe mpox infections requiring antiviral intervention.
Bimagrumab Plus Semaglutide for Obesity Management: Analysis of a Phase 2 Randomized Controlled Trial Demonstrating Enhanced Weight Reduction with Lean Mass Preservation
A phase 2 randomized controlled trial demonstrated that the combination of bimagrumab and semaglutide achieved superior weight reduction compared with semaglutide monotherapy while preserving lean muscle mass. The combination therapy resulted in a least squares mean weight loss of 17.8 kg versus 14.2 kg with semaglutide alone at 48 weeks.